Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | TAXS.OB, MNTA, CRWEWallstreet.com Stock Highlight on Friday July.23.2010TaxMasters, Inc., the IRS tax relief company, is the first publicly traded tax representation firm in the United States.
By: Hanson After each fiscal year during the five years that Mr. Cox’s shares are being held in escrow, Mr. Cox may claw back a portion of the escrowed shares based on a formula linked to the financial performance of TaxMasters. Any shares Mr. Cox does not claw back prior to June 30, 2015 will be turned over to the Company for cancellation. As a result of the Financial Reorganization Agreement, shareholders will have an increased voting power in their stock. For example, a shareholder owning 1,000,000 shares of TaxMasters common stock will have an increase of the voting power of such stock from 0.3% of the voting power to 0.7% of the voting power. TaxMasters, Inc., the IRS tax relief company, is the first publicly traded tax representation firm in the United States. Started by Patrick R. Cox in 2001, TaxMasters offers services and counsel to taxpayers across the country facing seemingly insurmountable tax problems, and relief from substantial federal tax debt. Employing over 300 people, TaxMasters leverages the expertise of ex-IRS agents, enrolled agents, attorneys, CPAs, and seasoned tax consultants ready to counsel and assist every day people with their specific tax problems today. More about TAXS at: www.txmstr.com. ************************************ Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will conduct a conference call to discuss the approval of generic Lovenox. Management will host a conference call today at 1:00 pm ET. To access the call, please dial (877) 224-9084 (domestic) or (720) 545-0022 (international) MNTA is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Shares of MNTA jumped $6.46 (+54.15%), up to $18.34 in market trading, today! Sign Up For Free Stock Alerts At http://crwewallstreet.com/ ************************************************************ THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!Disclaimer: End
Account Email Address Disclaimer Report Abuse
|
|